-
Je něco špatně v tomto záznamu ?
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer
D. Cibula, NR. Abu-Rustum, L. Dusek, M. Zikán, A. Zaal, L. Sevcik, GG. Kenter, D. Querleu, R. Jach, AS. Bats, G. Dyduch, P. Graf, J. Klat, J. Lacheta, CJ. Meijer, E. Mery, R. Verheijen, RP. Zweemer,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- biopsie sentinelové lymfatické uzliny MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymfatické metastázy MeSH
- lymfatické uzliny patologie MeSH
- nádory děložního čípku patologie MeSH
- prediktivní hodnota testů MeSH
- přežití bez známek nemoci MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- staging nádorů MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: Evaluate prognostic significance of low volume disease detected in sentinel nodes (SN) of patients with early stages cervical cancer. Although pathologic ultrastaging of SN allows for identification of low volume disease, including micro-metastasis and isolated tumor cells (ITC), in up to 15% of cases, prognostic significance of these findings is unknown. METHODS: A total of 645 records from 8 centers were retrospectively reviewed. Enrolled in our study were patients with early-stage cervical cancer who had undergone surgical treatment including SN biopsy followed by pelvic lymphadenectomy and pathologic ultrastaging of SN. RESULTS: Macrometastasis, micrometastasis, and ITC were detected by SN ultrastaging in 14.7%, 10.1%, and 4.5% patients respectively. False negativity of SN ultrastaging reached 2.8%. The presence of ITC was not associated with significant risk, both for recurrence free survival and overall survival. Overall survival was significantly reduced in patients with macrometastasis and micrometastasis; hazard ratio for overall survival reached 6.85 (95% CI, 2.59-18.05) and 6.86 (95% CI, 2.09-22.61) respectively. Presence of micrometastasis was an independent prognostic factor for overall survival in a multivariable model. CONCLUSION: Presence of micrometastasis in SN in patients with early stage cervical cancer was associated with significant reduction of overall survival, which was equivalent to patients with macrometastasis. No prognostic significance was found for ITC. These data highlight the importance of SN biopsy and pathologic ultrastaging for the management of cervical cancer.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024240
- 003
- CZ-PrNML
- 005
- 20121207103717.0
- 007
- ta
- 008
- 120815s2012 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ygyno.2011.11.037 $2 doi
- 035 __
- $a (PubMed)22120175
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cibula, D $u Gynecological Oncology Centre, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. david.cibula@iol.cz
- 245 10
- $a Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer / $c D. Cibula, NR. Abu-Rustum, L. Dusek, M. Zikán, A. Zaal, L. Sevcik, GG. Kenter, D. Querleu, R. Jach, AS. Bats, G. Dyduch, P. Graf, J. Klat, J. Lacheta, CJ. Meijer, E. Mery, R. Verheijen, RP. Zweemer,
- 520 9_
- $a OBJECTIVE: Evaluate prognostic significance of low volume disease detected in sentinel nodes (SN) of patients with early stages cervical cancer. Although pathologic ultrastaging of SN allows for identification of low volume disease, including micro-metastasis and isolated tumor cells (ITC), in up to 15% of cases, prognostic significance of these findings is unknown. METHODS: A total of 645 records from 8 centers were retrospectively reviewed. Enrolled in our study were patients with early-stage cervical cancer who had undergone surgical treatment including SN biopsy followed by pelvic lymphadenectomy and pathologic ultrastaging of SN. RESULTS: Macrometastasis, micrometastasis, and ITC were detected by SN ultrastaging in 14.7%, 10.1%, and 4.5% patients respectively. False negativity of SN ultrastaging reached 2.8%. The presence of ITC was not associated with significant risk, both for recurrence free survival and overall survival. Overall survival was significantly reduced in patients with macrometastasis and micrometastasis; hazard ratio for overall survival reached 6.85 (95% CI, 2.59-18.05) and 6.86 (95% CI, 2.09-22.61) respectively. Presence of micrometastasis was an independent prognostic factor for overall survival in a multivariable model. CONCLUSION: Presence of micrometastasis in SN in patients with early stage cervical cancer was associated with significant reduction of overall survival, which was equivalent to patients with macrometastasis. No prognostic significance was found for ITC. These data highlight the importance of SN biopsy and pathologic ultrastaging for the management of cervical cancer.
- 650 _2
- $a přežití bez známek nemoci $7 D018572
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymfatické uzliny $x patologie $7 D008198
- 650 _2
- $a lymfatické metastázy $7 D008207
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a biopsie sentinelové lymfatické uzliny $7 D021701
- 650 _2
- $a nádory děložního čípku $x patologie $7 D002583
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Abu-Rustum, N R $7 gn_A_00000925
- 700 1_
- $a Dusek, L
- 700 1_
- $a Zikán, M
- 700 1_
- $a Zaal, A
- 700 1_
- $a Sevcik, L
- 700 1_
- $a Kenter, G G
- 700 1_
- $a Querleu, D
- 700 1_
- $a Jach, R
- 700 1_
- $a Bats, A S
- 700 1_
- $a Dyduch, G
- 700 1_
- $a Graf, P
- 700 1_
- $a Klat, J
- 700 1_
- $a Lacheta, J
- 700 1_
- $a Meijer, C J L M
- 700 1_
- $a Mery, E
- 700 1_
- $a Verheijen, R
- 700 1_
- $a Zweemer, R P
- 773 0_
- $w MED00001958 $t Gynecologic oncology $x 1095-6859 $g Roč. 124, č. 3 (2012), s. 496-501
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22120175 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20121207103751 $b ABA008
- 999 __
- $a ok $b bmc $g 946388 $s 781568
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 124 $c 3 $d 496-501 $i 1095-6859 $m Gynecologic oncology $n Gynecol Oncol $x MED00001958
- LZP __
- $a Pubmed-20120815/12/02